These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 30025252)

  • 1. MK-2206, an allosteric inhibitor of AKT, stimulates LDLR expression and LDL uptake: A potential hypocholesterolemic agent.
    Bjune K; Sundvold H; Leren TP; Naderi S
    Atherosclerosis; 2018 Sep; 276():28-38. PubMed ID: 30025252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Triciribine increases LDLR expression and LDL uptake through stabilization of LDLR mRNA.
    Bjune K; Wierød L; Naderi S
    Sci Rep; 2018 Nov; 8(1):16174. PubMed ID: 30385871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alginate oligosaccharide enhances LDL uptake via regulation of LDLR and PCSK9 expression.
    Yang JH; Bang MA; Jang CH; Jo GH; Jung SK; Ki SH
    J Nutr Biochem; 2015 Nov; 26(11):1393-400. PubMed ID: 26320675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hsa-miR-140-5p down-regulates LDL receptor and attenuates LDL-C uptake in human hepatocytes.
    Xu Y; Gao J; Gong Y; Chen M; Chen J; Zhao W; Tan S
    Atherosclerosis; 2020 Mar; 297():111-119. PubMed ID: 32109664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of AKT kinase increase LDL receptor mRNA expression by two different mechanisms.
    Bjune K; Wierød L; Naderi S
    PLoS One; 2019; 14(6):e0218537. PubMed ID: 31216345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Resveratrol increases the expression and activity of the low density lipoprotein receptor in hepatocytes by the proteolytic activation of the sterol regulatory element-binding proteins.
    Yashiro T; Nanmoku M; Shimizu M; Inoue J; Sato R
    Atherosclerosis; 2012 Feb; 220(2):369-74. PubMed ID: 22153697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein phosphatase 2A (PP2A) regulates low density lipoprotein uptake through regulating sterol response element-binding protein-2 (SREBP-2) DNA binding.
    Rice LM; Donigan M; Yang M; Liu W; Pandya D; Joseph BK; Sodi V; Gearhart TL; Yip J; Bouchard M; Nickels JT
    J Biol Chem; 2014 Jun; 289(24):17268-79. PubMed ID: 24770487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deferoxamine stimulates LDLR expression and LDL uptake in HepG2 cells.
    Guillemot J; Asselin MC; Susan-Resiga D; Essalmani R; Seidah NG
    Mol Nutr Food Res; 2016 Mar; 60(3):600-8. PubMed ID: 26577249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin enhances cell-surface LDLR level and promotes LDL uptake through downregulation of PCSK9 gene expression in HepG2 cells.
    Tai MH; Chen PK; Chen PY; Wu MJ; Ho CT; Yen JH
    Mol Nutr Food Res; 2014 Nov; 58(11):2133-45. PubMed ID: 25164566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proprotein Convertase Subtilisin Kexin Type 9 Inhibition for Autosomal Recessive Hypercholesterolemia-Brief Report.
    Thedrez A; Sjouke B; Passard M; Prampart-Fauvet S; Guédon A; Croyal M; Dallinga-Thie G; Peter J; Blom D; Ciccarese M; Cefalù AB; Pisciotta L; Santos RD; Averna M; Raal F; Pintus P; Cossu M; Hovingh K; Lambert G
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1647-50. PubMed ID: 27079874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor.
    Huang Z; Zhou X; Nicholson AC; Gotto AM; Hajjar DP; Han J
    Br J Pharmacol; 2008 Oct; 155(4):596-605. PubMed ID: 18852694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. JD induced pluripotent stem cell-derived hepatocytes faithfully recapitulate the pathophysiology of familial hypercholesterolemia.
    Cayo MA; Cai J; DeLaForest A; Noto FK; Nagaoka M; Clark BS; Collery RF; Si-Tayeb K; Duncan SA
    Hepatology; 2012 Dec; 56(6):2163-71. PubMed ID: 22653811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diallyl disulfide improves lipid metabolism by inhibiting PCSK9 expression and increasing LDL uptake via PI3K/Akt-SREBP2 pathway in HepG2 cells.
    Wu YR; Li L; Sun XC; Wang J; Ma CY; Zhang Y; Qu HL; Xu RX; Li JJ
    Nutr Metab Cardiovasc Dis; 2021 Jan; 31(1):322-332. PubMed ID: 33500108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake.
    Haskins JW; Zhang S; Means RE; Kelleher JK; Cline GW; Canfrán-Duque A; Suárez Y; Stern DF
    Sci Signal; 2015 Nov; 8(401):ra111. PubMed ID: 26535009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homozygous Familial Hypercholesterolemia Patients With Identical Mutations Variably Express the LDLR (Low-Density Lipoprotein Receptor): Implications for the Efficacy of Evolocumab.
    Thedrez A; Blom DJ; Ramin-Mangata S; Blanchard V; Croyal M; Chemello K; Nativel B; Pichelin M; Cariou B; Bourane S; Tang L; Farnier M; Raal FJ; Lambert G
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):592-598. PubMed ID: 29284604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential effects of red yeast rice, Berberis aristata and Morus alba extracts on PCSK9 and LDL uptake.
    Lupo MG; Macchi C; Marchianò S; Cristofani R; Greco MF; Dall'Acqua S; Chen H; Sirtori CR; Corsini A; Ruscica M; Ferri N
    Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1245-1253. PubMed ID: 31439394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Atorvastatin increases expression of low-density lipoprotein receptor mRNA in human circulating mononuclear cells.
    Pocathikorn A; Taylor RR; Mamotte CD
    Clin Exp Pharmacol Physiol; 2010 Apr; 37(4):471-6. PubMed ID: 19930424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piceatannol reduces resistance to statins in hypercholesterolemia by reducing PCSK9 expression through p300 acetyltransferase inhibition.
    Kim HJ; Lee J; Chung MY; Hong S; Park JH; Lee SH; Park SW; Choi HK; Hwang JT
    Pharmacol Res; 2020 Nov; 161():105205. PubMed ID: 32998069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extra Virgin Olive Oil Phenol Extracts Exert Hypocholesterolemic Effects through the Modulation of the LDLR Pathway: In Vitro and Cellular Mechanism of Action Elucidation.
    Lammi C; Bellumori M; Cecchi L; Bartolomei M; Bollati C; Clodoveo ML; Corbo F; Arnoldi A; Mulinacci N
    Nutrients; 2020 Jun; 12(6):. PubMed ID: 32526887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of HMG-CoA reductase, apoprotein-B and LDL receptor gene expression by the hypocholesterolemic drugs simvastatin and ciprofibrate in Hep G2, human and rat hepatocytes.
    Qin W; Infante J; Wang SR; Infante R
    Biochim Biophys Acta; 1992 Jul; 1127(1):57-66. PubMed ID: 1627634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.